Infection Control Market Report 2025 (Global Edition)

Global Infection Control Market Report 2025 Market Size Split by Product type (Sterilization equipment, Cleaning & disinfectant product, Protective barrier, Endoscope reprocessing product), by Applica...

Infection Control Market Report Description

We have various report editions of Infection Control Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Infection Control Market Insights Video

Infection Control Market News

• July 2022

Amity international acquire Belimed:
Amity international manufacturing chemical speciality has taken the Belimed company. Amity International has created a variety of products in the health sector.  

• August 2021

Fortive company launch new product STERRAD VELOCITY

In the Asia Pacific area, Advanced Sterilization Products, a Fortive firm, introduced the STERRAD VELOCITY, a type of biological indicator (BI)/process challenge device (PCD).

• September 2022

STERIS inaugurated a brand-new medical device testing the centre.

In Leipzig, Germany, STERIS inaugurated a brand-new medical device testing centre. The production of medical devices will take place in this new facility. It complements the current E-beam, the gamma and testing services provided in Germany and includes extra packaging and microbiological analysis capabilities.

Top Companies Market Share in Infection Control Industry: (In no particular order of Rank)

• 3m
• MMM group
• STERIS
• Gettinge Ab
• Halyard health
• Metrex research
• Fortives
• Belimed
• Pal international
• Miele group
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

North America Infection Control is anticipated to witness the remarkable growth:

North America is predicted to have considerable growth. The government authorities also take action in the areas of recent launches of products and infection control. For the healthcare sector, Getinge AB has introduced an innovative 9100E Cart Washer within the United States. 
The Asia-Pacific area is projected to have profitable market expansion as a result of the developing healthcare sector, rising disposable income, and increasing expenditures in infection control by healthcare providers. Furthermore, it is predicted that over the course of the projection period, sales growth will be aided by infection control activities and the growing incidence of hospital-acquired illnesses in the area.

The current report Scope analyzes Infection Control Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Infection Control Market Analysis

Infection Control Market, By Product type

By product type infection control segment is divided into sterilization equipment, cleaning and disinfectant products, protective barrier, endoscope reprocessing products. The requirement for eradicating all microbiological life, particularly viruses, fungi, bacteria, spores, and viruses, will increase during the projection period, which will lead to a quick increase in the revenue for sterilization equipment. Sterile equipment eliminates pathogenic bacteria and neutralises further hazardous organisms. Radiation sterilization successfully kills bacteria, makes packaging possible, and protects the security of medical supplies. Radiation sterilisation provides a secure and affordable way to sterilise disposable medical equipment including syringes and surgical gloves. One of its benefits is that it enables sterilization of products that are already packaged.  It ensures the safety of surgical treatments and lessens the ability to nest habitat for surviving pathogenic organisms.

• Sterilization equipment
• Cleaning & disinfectant product
• Protective barrier
• Endoscope reprocessing product

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Infection Control Industry. Request a Free Sample PDF!

Infection ControlMarket, By Application

The application infection control segment is divided into infectious waste disposal, sterilization consumable, disinfectant and personal protective equipment. The demand for disinfectants to kill microorganisms on non-living surfaces is projected to increase, which will lead to a strong revenue growth rate for the disinfection market over the forecast period. Utilising disinfectants can help stop the transfer of viruses from surfaces to soiled cleaning cloths and sponges.

• Infectious waste disposal
• Sterilization consumable 
• Disinfectant & personal protective equipment

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Infection Control End-User Segment Analysis

Infection ControlMarket, By End-User

By end user infection control segment is subdivided into hospitals and clinics, life science, medical devices, pharmaceutical, food and other. The hospital and clinics industry is anticipated to have rapid revenue growth throughout the projection period. Hospital infection control measures include identifying patients who are susceptible to nosocomial infections, enforcing hand hygiene, adhering to standard precautions to prevent transmission, and lowering the incidence of ventilator-associated pneumonia (VAP), catheter-related bloodstream infection (CRBSI), and catheter-associated urinary tract infection (CAUTI). Hospitals are putting more of an emphasis on infection control and preventive measures, such as cleanliness of the hands, surgical site infections, safe injection practices, and antimicrobial resistance. To prevent medical staff from coming into contact with patients who are carrying various infectious diseases, preventative measures are also commonly used in hospitals. This results in expansion of the infection control market.

• Hospital & clinics
• Life science
• Medical devices
• Pharmaceutical
• Food
• other

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion